Health Canada drug identification number

DIN 02563886 — TRYNGOLZA 80 MG

TRYNGOLZA is a solution of Olezarsen marketed by CELYSTRA PHARMA INC.. The full Olezarsen monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02563886
Brand name
TRYNGOLZA
Active ingredient
Olezarsen
Strength
80 MG
Dosage form
SOLUTION
Route
SUBCUTANEOUS
Manufacturer
CELYSTRA PHARMA INC.
Health Canada status
MARKETED
Drug class
Apolipoprotein C-III-directed antisense oligonucleotide (lipid-modifying agent)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.